Johnson & Johnson
Eli Lilly
NBC
the Brown University School of Public
Eli Lilly's
Ricks
information."The Johnson & Johnson
AstraZeneca
the Food and Drug Administration
FDA
COVID-19
the White House
Trump admin's
the Scripps Research Institute
the National Institutes of Health
Topol
SponsoredThe
NW Suite 900 Washington DC
Capitol Hill Publishing Corp.
News Communications
Ashish Jha
David Ricks
John TrumpLabor
Eric Topol
British
COVID-19
No matching tags
1625 K Street
U.S.
Russia
Inc.
No matching tags
Two pharmaceutical giants this week became the latest drug companies to halt clinical trials into potential COVID-19 vaccines and treatments because of potential safety concerns, putting a renewed focus on transparency and public confidence.Johnson & Johnson announced on Monday that a late-stage trial of its vaccine candidate had been paused because of a potential vaccine-linked illness in a participant.A day later, Eli Lilly hit the brakes on its government-sponsored trial of a monocolonal antibody drug to treat hospitalized coronavirus patients due to a safety concern.Experts said the public should be reassured by those decisions because it means the vaccine trial system is working to protect patient safety as intended.During a Wednesday interview with NBC’s “Today Show,” Ashish Jha, dean of the Brown University School of Public, said he was "heartened" by the news that the companies had hit speed bumps."I'm really heartened by these things.
As said here by Nathaniel Weixel